期刊文献+

甲状腺功能亢进症患者药物治疗依从性影响因素分析 被引量:2

Analysis of factors influencing drug treatment compliance in patients with hyperthyroidism
原文传递
导出
摘要 目的分析甲状腺功能亢进症患者药物治疗依从性的影响因素。方法选择2015年1月-2017年12月药物治疗的甲状腺功能亢进症患者88例,比较不同情况患者的依从性,并进行单因素与多因素分析。结果88例患者中依从性好58例(65. 91%),依从性差30例(34. 09%)。单因素检验:不同年龄、性别、文化层次、婚姻状态、月收入、心理反应、家庭支持、甲状腺功能亢进症及药物治疗知识、医疗费用、药物治疗不良反应、医患关系患者的依从性比较差异均有统计学意义(P <0. 05)。Logistic回归分析:甲状腺功能亢进症药物治疗依从性影响因素为甲状腺功能亢进症及药物治疗知识缺少(OR=4. 69,95%CI:1. 26-19. 29)、药物治疗不良反应(OR=4. 18,95%CI:2. 02-21. 28)、存在心理反应不良(OR=3. 30,95%CI:1. 48-18. 20)、患者年龄≥60岁(OR=2. 95,95%CI:1. 31-17. 06)。结论甲状腺功能亢进症患者药物治疗依从性较差,影响因素多种多样,应实施针对性措施提高甲状腺功能亢进症患者药物治疗依从性。 Objective To analyze the influencing factors of drug treatment compliance in patients with hyperthyroidism. Methods 88 cases of patients with hyperthyroidism who were treated with drugs from January 2015 to December 2017 were selected,the treatment compliance of different patients was compared,and single factor and multivariate analysis were performed. Results Among the 88 patients,58 patients (65. 91%) had good compliance,and 30 patients (34. 09%) had poor compliance. Univariate test:the differences in compliance between patients of different age,gender,cultural level,marital status,monthly income,psychological response,family support,hyperthyroidism and drug treatment knowledge,medical expenses, adverse drug reactions,and doctor-patient relationship were statistically significant(P < 0. 05). Logistic regression analysis: lack of knowledge of hyperthyroidism and drug therapy(OR = 4. 69,95% CI:1. 26. 19. 29),adverse drug reactions(OR = 4. 18,95%CI:2. 02 -21. 28),there was a poor psychological reaction(OR =3. 30,95% CI:1. 48 -18. 20),and the patients' age was ≥60 years old(OR =2. 95,95%CI:1. 31 -17. 06) were the influencing factors of medication compliance for hyperthyroidism. Conclusion The compliance of the patients with hyperthyroidism is poor and the influencing factors are varied,the compliance measures should be carried out to improve the compliance of the patients with hyperthyroidism.
作者 郝艳 HAO Yan(Department of Endocrinology,Taihu Hospital of Wuxi,Jiangsu Province,Wuxi 224000,China)
出处 《临床合理用药杂志》 2018年第34期23-25,共3页 Chinese Journal of Clinical Rational Drug Use
关键词 甲状腺功能亢进症 药物治疗 依从性 影响因素 Hyperthyroidism Drug therapy Compliance Influencing factors
  • 相关文献

参考文献10

二级参考文献93

  • 1洪天配,宋延利,孙体,李琼芳,李佑成.高灵敏TSH IRMA动态监测在甲亢诊疗和预测复发中的意义[J].中华内分泌代谢杂志,1996,12(2):119-120. 被引量:15
  • 2李卫红,吕建新,张建国,刘书院.抗甲状腺药物治疗Graves病的疗效与疗程观察[J].中国医药导报,2007,4(06X):64-65. 被引量:6
  • 3中华医学会内分泌学分会《中国甲状腺疾病诊治指南》编写组.中国甲状腺疾病诊治指南-甲状腺功能亢进症[J].中华内科杂志,2007,46:876-882.
  • 4中国甲状腺疾病诊治指南——甲状腺功能亢进症[J].中华内科杂志,2007,46(10):876-882. 被引量:846
  • 5Sundaresh V,Brito JP,Wang Z,et al.Comparative effectiveness of therapies for Graves'hyperthyroidism:a systematic review and netw ork meta-analysis[J].J Clin Endocrinol M etab,2013,98(9):3671-3677.
  • 6Choo YK,Yoo WS,Kim DM,et al.Hypothyroidism during antithyroid drug treatment with methimazole is a favorable prognostic indicator in patients with Graves'disease[J].Thyroid,2010,20(9):949-954.
  • 7Franklyn JA,Boelaert K.Thyrotoxicosis[J].Lancet,2012,379(9821):1155-1166.
  • 8Karras S,Memi E,Kintiraki E,et al.Pathogenesis of propylthiouracil-related hepatotoxicity in children:present concepts[J].Pediatr Endocrinol Metab,2012,25(7):623.
  • 9Bartalena L.Diagnosis and management of Graves disease:a global overview[J].Nat Rev Endocrinol,2013,9(12):724-734.
  • 10Sato H,Minagawa M,Sasaki N,et al.Comparison of methimazole and Propylthiouracil in the management of children and adolescents with Graves'disease:efficacy and adverse reactions during initial treatment and long-term outcome[J].J Pediatr Endocrinol M etab,2011,24(5-6):257-263.

共引文献125

同被引文献20

引证文献2

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部